Amia Capital LLP Moderna, Inc. Transaction History

Amia Capital LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $338,730 - $552,765	-1,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $332,850 - $726,705	1,500 New	1,500 $577,000
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $1.16 Million - $2.99 Million	-17,607 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $241,323 - $421,228	-4,441 Reduced 20.14%	17,607 $1.25 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $591,768 - $1.6 Million	-19,945 Reduced 47.5%	22,048 $1.42 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $197,055 - $350,001	-11,083 Reduced 20.88%	41,993 $1.26 Million
Q4 2019 Feb 13, 2020	BUY	$13.93 - $21.28 $739,348 - $1.13 Million	53,076 New	53,076 $1.04 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.